TECHNOLOGY
R&D
Bioelectronic Medicine R&D
Bioelectronic Medicine is a personalized medical device that electrically mimics biological signals generated within the body and delivers them directly to disease-related neural tissues to induce specific biological functions that may help treat disease.
Electroceutical technologies can be implemented as wearable or implantable devices, allowing patients to receive treatment independently at home or during everyday activities.
Research & Development
Nu Eyne is developing electroceutical technologies as a new therapeutic alternative for chronic diseases where conventional treatments often face limitations due to side effects or insufficient efficacy.
The company is conducting clinical validation studies to apply its technology across a broad range of indications, including:
Nu Eyne researches and develops customized microcurrent stimulation protocols to regulate abnormal neural activity associated with various diseases.
Neural activity modulation technology non-invasively stimulates peripheral nerves, such as the trigeminal nerve and vagus nerve, to activate connected pathways within the central nervous system and other neural networks.
The stimulation-induced neural signals are transmitted through brainstem structures, including Nucleus Tractus Solitarius (NTS), Locus Coeruleus (LC), Raphe Nuclei (RN). These neural pathways ultimately project to the cerebral cortex, where they regulate brain activity and function.
Nu Eyne researches and develops customized microcurrent stimulation protocols to accelerate the recovery of damaged tissues and nerves according to the affected area.
Tissue regeneration induction technology utilizes voltage gradients and electric fields generated by microcurrents to promote cellular proliferation and migration while guiding the direction of cell movement, thereby accelerating tissue and nerve recovery.
Microcurrent stimulation applied to damaged nerves promotes the expression of:
Nu Eyne researches and develops reversible electric field stimulation protocols to inhibit cancer cell proliferation and induce cancer cell death.
Reversible electric field stimulation can induce cancer cell death through multiple biological mechanisms.
Key mechanisms include:
This immune activation may improve the therapeutic efficacy of cancer immunotherapies.
Bioelectronic Medicine R&D
Bioelectronic Medicine is a personalized medical device that electrically mimics biological signals generated within the body and delivers them directly to disease-related neural tissues to induce specific biological functions that may help treat disease.
Electroceutical technologies can be implemented as wearable or implantable devices, allowing patients to receive treatment independently at home or during everyday activities.
.
Research & Development
Nu Eyne is developing electroceutical technologies as a new therapeutic alternative for chronic diseases where conventional treatments often face limitations due to side effects or insufficient efficacy.
The company is conducting clinical validation studies to apply its technology across a broad range of indications, including:
Neural activity modulation technology non-invasively stimulates peripheral nerves, such as the trigeminal nerve and vagus nerve, to activate connected pathways within the central nervous system and other neural networks.
The stimulation-induced neural signals are transmitted through brainstem structures, including Nucleus Tractus Solitarius (NTS), Locus Coeruleus (LC), Raphe Nuclei (RN). These neural pathways ultimately project to the cerebral cortex, where they regulate brain activity and function.
Tissue regeneration induction technology utilizes voltage gradients and electric fields generated by microcurrents to promote cellular proliferation and migration while guiding the direction of cell movement, thereby accelerating tissue and nerve recovery.
Microcurrent stimulation applied to damaged nerves promotes the expression of:
Reversible electric field stimulation can induce cancer cell death through multiple biological mechanisms.
Key mechanisms include:
This immune activation may improve the therapeutic efficacy of cancer immunotherapies.
